Detalhe da pesquisa
1.
CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy.
Blood
; 143(21): 2152-2165, 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38437725
2.
Corrigendum: Combination of T-Cell Bispecific Antibodies With PD-L1 Checkpoint Inhibition Elicits Superior Anti-Tumor Activity.
Front Oncol
; 11: 650149, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33614518
3.
Combination of T-Cell Bispecific Antibodies With PD-L1 Checkpoint Inhibition Elicits Superior Anti-Tumor Activity.
Front Oncol
; 10: 575737, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33330050
4.
CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies.
Clin Cancer Res
; 24(19): 4785-4797, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29716920